Nuveen Asset Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-133,751
| Closed | -$425K | – | 3473 |
|
|
2022
Q1 | $425K | Buy |
133,751
+1,002
| +0.8% | +$3.18K | ﹤0.01% | 3059 |
|
|
2021
Q4 | $564K | Sell |
132,749
-18,652
| -12% | -$79.2K | ﹤0.01% | 3047 |
|
|
2021
Q3 | $727K | Buy |
151,401
+2,858
| +2% | +$13.7K | ﹤0.01% | 3093 |
|
|
2021
Q2 | $1.01M | Sell |
148,543
-10,342
| -7% | -$70.5K | ﹤0.01% | 2999 |
|
|
2021
Q1 | $1.12M | Sell |
158,885
-6,388
| -4% | -$45.1K | ﹤0.01% | 2851 |
|
|
2020
Q4 | $1.04M | Sell |
165,273
-20,987
| -11% | -$131K | ﹤0.01% | 2794 |
|
|
2020
Q3 | $1.01M | Buy |
186,260
+60,025
| +48% | +$325K | ﹤0.01% | 2691 |
|
|
2020
Q2 | $659K | Sell |
126,235
-67,222
| -35% | -$351K | ﹤0.01% | 2795 |
|
|
2020
Q1 | $610K | Buy |
193,457
+87,258
| +82% | +$275K | ﹤0.01% | 2700 |
|
|
2019
Q4 | $428K | Sell |
106,199
-14,675
| -12% | -$59.1K | ﹤0.01% | 2941 |
|
|
2019
Q3 | $522K | Sell |
120,874
-7,338
| -6% | -$31.7K | ﹤0.01% | 2935 |
|
|
2019
Q2 | $512K | Buy |
+128,212
| New | +$512K | ﹤0.01% | 2992 |
|